MOOLEC SCIENCE SA

MLECNASDAQ

🏆 #4598 by market capUS Equity

$6.88▼ $0.20 (−2.85%)

Live

1h—

24h▼ 2.9%

7d▼ 15.1%

14d▼ 15.1%

30d▼ 6.2%

1y▼ 83.1%

🏦Market Cap

$5M

Small Cap

📈Revenue Growth (YoY)

+5830.7%

High Growth

📊Gross Margin

34.2%

Moderate

💵FCF Margin

-9.0%

Thin

⚖️P/S Ratio

0.0x

Cheap

Otter Score

Weak

Trading Snapshot

Day Range: $6.81 – $6.97
52-Week Range: $3.08 – $43.05
Volume: $2.53B
Avg Volume: $2.03B
Shares Outstanding: 726,118
Next Earnings: Sep 19, 2026

Fundamentals Snapshot

Annual Revenue: $334M
Last Q Revenue: $3M
P/E Ratio: -0.0
P/S Ratio: 0.0x
EPS (TTM): $-258.69
Dividend Yield: 0.00%

Why Investors Own MLEC

✓High-growth profile — revenue up +32.9% YoY with expanding US Equity exposure.
✓Healthy economics — 44% gross margin and 4% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$334M▲ +37.2% YoY

Gross Margin (TTM)

43.6%▲ +2.2% YoY

Operating Income (TTM)

$60M▲ +37.2% YoY

Free Cash Flow (TTM)

$14M▲ +37.2% YoY

About MOOLEC SCIENCE SA

Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally. It develops nutritional supplements, food ingredients, meat replacements, and by-products using safflowers, chickpeas, fungi, soybeans, and yeast, as well as lupin and peas. The company is based in Grand Cayman, Cayman Islands.

🦦